Answer
Apr 17, 2026 - 11:09 AM
The active ingredient in Ubrelvy is ubrogepant, which is a calcitonin gene-related peptide (CGRP) receptor antagonist. CGRP is a protein involved in migraine pain signaling, and blocking its action can reduce headache severity. This mechanism is valuable for those who may not respond well to other migraine treatments.
